The purpose of this study is to evaluate the efficacy of sunobinop compared to placebo on alcohol consumption in subjects with alcohol use disorder.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
200
1 tablet taken orally at bedtime
1 tablet taken orally at bedtime
Belmont Medical Office
Brooklyn, New York, United States
Ohio Clinical Trials
Columbus, Ohio, United States
Inquest Clinical Research
Baytown, Texas, United States
Cebis Usa, Llc
Houston, Texas, United States
Percent heavy drinking days (HDD)
Time frame: Day 57
Number of standard unit drinks
Time frame: Day 57
Percent of drinking days (PDD)
Time frame: Day 57
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Bio Terra Med SRL
Bucharest, Romania
Spitalul Universitar De Urgenta Militar Central "Dr. Carol Davila"
Bucharest, Romania
Cabinet Medical Individual Dr. Andreea Popa
Bucharest, Romania